| |
PSI-938 and PSI-7977 as monotherapy and in combination & INX189 Monotherapy
|
| |
| |
ONCE DAILY DUAL-NUCLEOTIDE COMBINATION OF PSI-938 ...
www.natap.org/2011/EASL/EASL_07.htm
Apr 3, 2011 - PSI-938 and PSI-7977 as monotherapy and in combination were ... Of note, PSI-7977 monotherapy produced HCV RNA reductions over 7 days
INX-189, dosed once-daily at 9, 25, 50 and 100 mg for seven days
Inhibitex Reports Positive Safety and Antiviral Data from Its Phase ...
www.natap.org/2011/EASL/EASL_90.htm
Apr 3, 2011 - INX-189, dosed once-daily at 9, 25, 50 and 100 mg for seven days, demonstrated potent and dose-dependent antiviral activity with median
INX189 Monotherapy at Higher Dose 200mg
AASLD: Antiviral Activity and Safety of INX-08189, a Nucleotide Polymerase Inhibitor, Following 7-Days of Oral Therapy in Naïve Genotype-1 HCV Patients - (11/07/11)
Inhibitex Nucelotide INX-189 Higher Dosing Increases Viral Load Reduction - Inhibitex reports third quarter financial results and recent corporate developments - (11/07/11)
|
|
| |
| |
|
|
|
